SERUM CARCINOEMBRYONIC ANTIGEN LEVEL INCREASES CORRELATE WITH TUMOR PROGRESSION IN PATIENTS WITH DIFFERENTIATED GASTRIC-CARCINOMA FOLLOWING NONCURATIVE RESECTION
- 1 July 1990
- journal article
- research article
- Vol. 50 (13) , 3952-3955
Abstract
Serum carcinoembryonic antigen (CEA) levels were determined serially in 30 preoperative and postoperative patients with differentiated and 47 with undifferentiated gastric cancers. Macroscopic noncurative resection of the stomach was done for those patients. There was no difference between survival curves in the differentiated and undifferentiated cases, and the 50% survival was 13.1 months for the differentiated group and 12.5 months for the undifferentiated group. Preoperative serum CEA levels were 10.4 .+-. 5.2 ng/ml for the differentiated and 4.0 .+-. 1.6 ng/ml for the undifferentiated cases, and CEA-positive rates were 20.0% for the differentiated and 14.9% for the undifferentiated cases. There was no difference in preoperative CEA values with regard to tissue types. In the course of tumor progression, CEA levels increased during the first postoperative year in the differentiated cases and related reciprocally to decreases in survival rates. Little change was noted in the undifferentiated cases. Therefore, the serial postoperative assay of serum CEA levels has predictability with regard to tumor progression in patients with a differentiated gastric cancer.This publication has 13 references indexed in Scilit:
- Carcinoembryonic Antigen in Gastric Cancer PatientsOncology, 1987
- Prognostic value of preoperative serum cea level compared to clinical staging IV. Histological grading and tumor type in colorectal and gastric cancerJournal of Surgical Oncology, 1986
- Localization of CEA, HCG, Lysozyme, alpha-1-antitrypsin, and alpha-1-antichymotrypsin in gastric cancer and prognosisVirchows Archiv, 1986
- Serum CEA levels facilitate detection of recurrences of cancer in patients after gastrectomySurgery Today, 1985
- Postoperative adjuvant chemotherapy for gastric carcinoma analysis of data on 1805 patients followed for 5 yearsCancer, 1984
- NEW APPROACH TO MANAGEMENT OF MALIGNANT ASCITES WITH A STREPTOCOCCAL PREPARATION, OK-432 .1. IMPROVEMENT OF HOST IMMUNITY AND PROLONGATION OF SURVIVAL1983
- Clinical studies on cell-mediated immunity in patients with malignant disease I. Effect of immunotherapy with OK-432 on lymphocyte subpopulation and phytomitogen responsivenessin vitroCancer, 1980
- Carcinoembryonic antigen levels in advanced gastric carcinomaCancer, 1978
- COLLABORATIVE CLINICAL-STUDY OF CARCINOEMBRYONIC ANTIGEN IN JAPAN1977
- SPECIFIC CARCINOEMBRYONIC ANTIGENS OF THE HUMAN DIGESTIVE SYSTEMThe Journal of Experimental Medicine, 1965